ABSTRACT
describes the building of a simulation model that supports policy evaluation for a national medical problem. Notice that the three trigonometric rate components represent cyclic effects with periods of one year, one week, and one day, respectively. Details of the procedure are described in these proceedings (Kuhl, Wilson, and Johnson 1995 Further discussion of allocation policies is presented in a later section.
When a donor arrives, the quality of the graft harvested from the donor is assessed. Data available at UNOS permits the modeling of graft quality to be a fimction of the age of the donor.
The graft is then offered to the patient ranked highest by the allocation policy taking into account the donor's and recipient's blood type, weight and age. In the latter case, the graft is used for research or other medical purposes.
When the graft is accepted by a patient, the patient is transplanted and removed from the waiting list.
The fiture status of the transplanted patient is then determined.
First, it is determined whether the patient will require another transplant because of graft failure.
In this case the patient is relisted at the transplant center that performed the transplant operation. Relist functions have been developed for each medical status using a technique developed by Kaplan and Meier (1974) .
The relist data was derived from the 1991-92 time period and allowed a two year follow-up period to determine if a patient was relisted. If the patient did not relist, their mortality following the transplant was determined. A logistic regression approach was employed for determining the mortality rate as a function of (a) transplant center volume (number of transplants per year); (b) patient condition as reflected by the patient's medical status; and (c) whether the patient had a previous transplant. A similar analysis was performed for the relist finction that revealed no significant effect of transplant center volume or previous transplant on the probability of relisting.
Status Change Event
As patients wait for a transplant, their medical status changes. When a patient arrives in the model an initial probability Figure 2 , the policy to be run can be selected and the form of the input data, historical or generated, is made. The starting year and run length and whether to clear statistics can be input.
The number of runs to be made is established and the editing of inputs and component modules can be done by selecting the EDIT INPUTS button. The selection of an animation is also aHowed, and the SIMUL4TE button initiates the desired simulation.
On the bottom of this user interface screen are tabs for selecting the four other user interface screens. The SUMMARY screen allows the browsing of outputs from :Tx5by"ReJ0n""" """"" """"" """"" """"" """"" """""""""""""""""""-"""-""-""""`"""""""""""""":
Txs"byReg;On"by" POptiaiOn" """""""""""""""""""""""""""`""""-""""""""""""```;: ;
;Total Deaths by Region Centers associated with the OPO at which a donor arrives.
Regional means the current UNOS regions.
Super-Regions mean the U.S. divided into three major geographical areas (east, middle, west). National means the entire country.
Note that a policy that specifies L1 first then R1 implies that ranking for Regioml -Status 1 excludes Local -Status 1 patients.
This complicates the ranking procedure for computing waiting time points as the waiting list changes depending on the location of a donor. Policy 1 is the current allocation policy and is designed to balance patient need for a transplant with successful transplant outcome. In order to limit organ travel distance, the policy allocates liver grafts to the local patients first, followed by regional patients, and then patients on the national list. Patients who have the highest medical urgency for a liver transplant are looked at first in any given level. Printouts of the matching of a donor to a patient and of the offering process were made and the models were For example, for the donor streams, the stochastic process that was generated over four years (199 1-94) was fitted with three years of data 1992, 1993, 1994, 1991-94 and 1992-94 .
Validation runs were made with each of these sets of transition probabilities.
During preliminary runs of the model, it was determined that a three year period was necessary in order to compare policies.
Thus, the validation runs were made for the period 1992 through 1994 with each of the transition probability matrices described above. In early validation runs, the fine detail of the model could not be reproduced and ULAM was rejected as a valid model for the liver transplantation process. In the validation runs, policy 1, the current policy, was used. After several weeks of performing validation exercises, it was uncovered that the policy in place from 1992 through November 1, 1994 differed from the current policy. The prior policy, named Policy O, grouped Status 2, 3 and 4 patients together whereas the current policy only groups Status 3 ancl 4 patients together. Validation runs were then made with Policy O operating for the first two years and ten mcmths of the third year, and then Policy 1 was in effect for the last two months of 1994. These validation runs produced results that were sufficiently close to actual r{esults that a comparison of policies based on ULAM was deemed to be appropriate.
The validation outputs for 1992-94 based on historical input streams and Markov chains based on both 1991-94 and 1992-94 data are presented in Figure 5 . An overview of the policy comparisons for the five policies assessed is given in Figure 6 . These results are for historical donor and patient arrivals during 1992 through 1994. These outputs show that the number of non-repeated transplants, that is, the number of different patients that are transplanted, differs over the five policies.
The difference increases as a policy transplants the sicker patients which have a higher relist probability.
When a patient is relisted, a numerically lower medical urgency status is typically assigned, giving relisted patients a higher priority for transplantation. This is reflected in the model output in terms of the number of different patients transplanted as well as the number of Status 1 patients transplanted. Pediatric patients usually are assigned a numerically lower medical urgency status and this is reflected in the number of pediatric transplants that occur for those policies that transplant Status 1 and Status 2 patients nationally prior to treating Status 3 patients locally or regionally.
The number of days in status is a cost-related measure, as it indicates the number of days patients would be in the hospital and in intensive care units. It can be seen that there area large number of patient-days in Status 3 which requires continuous medical monitoring and, if these patients are in the hospitat, would reflect an added cost for those policies that have a low percentage of transplants for Status 3 patients. The share type measures relate to the use of grafts locally.
Currently there is a debate in the transplantation community as to whether a low percentage of grafts used locally would adversely affect the donor rate. If it does, there is a secondary effect, not included in ULAM, of a potential decrease in the donor arrival rate for such policies.
In the outputs presented in Figure 6 , In an attempt to quanti@ deaths that occur after the simulation, the time of death for those patients transplanted was projected and then discounted back to the end of the simulation. For those on the waiting list, a projection of the number of pre-transplant deaths occurring after the simulation under the condition of no donor arrivals was made. This involved performing a Markov chain analysis to determine the expected number of deaths on a given day after the simulation period and then discounting it back to the final day of the simulation period. An analytic model was developed for this purpose to arrive at the discounted after simulation waiting list deaths. Results for a discount factor of 0.2 are shown in Figure 6 . In If the discounted after simulation "deaths" are added to the total pre-and post-transplant deaths, then the total simulation period "deaths" show a surprising similarity for the five policies evaluated.
This was not expected as the five policies selected for evaluation were considered to be different with regard to the death measures included in the analysis.
Another surprising result is that the number of patients removed from the list over the three year period are all similar.
This was not the case for 1 and 2 year runs. An extensive number of waiting time measures are estimated using ULAM. Only two such measures are presented in Figure 6 . Other waiting time measures are time to removal, time in last status before transplant, ' -. 
